Document Classification

Section Type: METHODS

Text: Patients age 11-19 years old receiving emetogenic chemotherapy were randomized 2:1 to aprepitant triple therapy (aprepitant [A] 125 mg p. o., dexamethasone [D] 8 mg p. o., and ondansetron [O] 0. 15 mg/kg i. v. t. i. d. day 1 ; A 80 mg, D 4 mg, and O 0. 15 mg/kg t. i. d. day 2 ; A 80 mg and D 4 mg day 3 ; and D 4 mg day 4) or a control regimen (D 16 mg and O 0. 15 mg/kg t. i. d. day 1 ; D 8 mg and O 0. 15 mg/kg t. i. d. day 2 ; and D 8 mg days 3 and 4).